Clinical Trial

A Clinical Trial to Assess the Pharmacokinetics, Safety, and Food Effect of AD-230 in Healthy Adults

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 1, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
A clinical trial to assess the pharmacokinetics, safety, and food effect of AD-230 in healthy adults
Trial Details
NCT Number NCT07618845
Lead Sponsor Addpharma Inc.
Conditions Chronic Liver Disease (CLD)
Enrollment 24 participants
Start Date 2026-05
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-01